Blog

01/07/2015

“For many years, I’ve suffered from severe depression, panic attacks, separation anxiety and obsessive-compulsive disorder. The depression got worse as I got older, and I was diagnosed with bipolar disorder. In 2012, I had a breakdown—I was on medication, but not the right kind or enough of a dose. I ended up in the hospital, where I saw a psychiatrist. After I was discharged, I continued to see her on an outpatient basis for two years.

12/30/2014

Flonase is now available as part of your innoviCares membership, along with nearly 100 other brand-name medications.

Your innoviCares card covers up to the difference in cost between brand Flonase and the generic, fluticasone propionate, allowing you to receive Flonase at a price similar to the generic alternative. If you choose to remain on the original brand-name Flonase, please provide your pharmacist with your innoviCares card and ask for brand.

12/16/2014

InnoviCares is pleased to announce that Rocaltrol® (calcitriol) and Tarceva® (erlotinib), manufactured by Hoffmann-La Roche, are now available as part of your innoviCares membership, along with nearly 100 other brand-name medications.   As with many brands covered on the innoviCares program, your innoviCares card will pay up to the difference in price between Tarceva and Rocaltrol, and their generic alternatives.  

12/11/2014

InnoviCares is pleased to announce the addition of four new brand name medications to the innoviCares program. These products are available immediately as part of your innoviCares membership, along with a growing list of other medications.

Simply present your innoviCares card to your pharmacist, along with your prescription, to get these brand name medications at the generic price. 

10/08/2014

On September 30, 2014, Health Canada issued an import ban on medications and drug ingredients from three factories in India – you can learn more here.

10/08/2014

InnoviCares was featured in The Globe & Mail's Special Report on The Future of Prescription Drugs as a program that empowers patient choice and a solution for benefit plan sustainability. The editorial includes interviews with patients, physicians, patient advocates and STI Technologies Limited's (innoviCares parent company) CEO, Steve Nicolle. To view the PDF of the article, click on the image below.

Pages